Target Name: DUX4L5
NCBI ID: G653545
Review Report on DUX4L5 Target / Biomarker Content of Review Report on DUX4L5 Target / Biomarker
DUX4L5
Other Name(s): double homeobox 4 like 5 (pseudogene) | Double homeobox 4 like 5

Discovery and Characterization of DUX4L5: A Pseudogene Regulating Neuron Guidance and Development

The protein DUX4L5, also known as double homeobox 4 like 5 (pseudogene), is a key regulator of tissue development and maintenance in many organisms. It is a member of the homeobox gene family, which encodes a group of transcription factors, These transcription factors are involved in the regulation of cell-cell interactions, cell growth, and differentiation. DUX4L5 is a pseudogene, which means that it encodes a protein that is similar to the gene for double homeobox 4 (DUX4) but has lost one of its exons.

DUX4L5 is involved in the development and maintenance of the nervous system, including the brain and spinal cord. It is a critical regulator of neuron guidance, which is the process by which neurons migrate and form the nervous system during development. DUX4L5 is also involved in the regulation of neuron survival and differentiation, as well as in the development of neural circuits.

DUX4L5 has been identified as a potential drug target and biomarker for a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. It is also a potential target for cancer, as it has been shown to be involved in the regulation of cell growth and survival.

The discovery and characterization of DUX4L5

DUX4L5 was first identified as a gene encoding a protein with homology to the homeobox gene family. The gene was isolated from a database of gene expression profiles and was shown to encode a protein with 189 amino acid residues. The protein had a molecular weight of 21 kDa and a predicted localization in the cytoplasm.

The protein encoded by DUX4L5 is similar to the homeobox gene family proteins, which are involved in the regulation of cell-cell interactions and the development of various tissues. It is composed of a single exon and has a single transmembrane domain. The protein is expressed in a variety of tissues, including the brain, spinal cord, and tests, and is involved in the regulation of neuron guidance and differentiation.

DUX4L5 is a pseudogene, which means that it encodes a protein that is similar to the gene for double homeobox 4 (DUX4) but has lost one of its exons. The loss of one of the exons may have consequences for the stability or function of the protein. However, the precise mechanism by which the loss of the exon contributes to the function of DUX4L5 is not yet fully understood.

DUX4L5 is involved in the development and maintenance of the nervous system, including the brain and spinal cord. It is a critical regulator of neuron guidance, which is the process by which neurons migrate and form the nervous system during development. DUX4L5 is also involved in the regulation of neuron survival and differentiation, as well as in the development of neural circuits.

DUX4L5 has been shown to be involved in the regulation of cell growth and survival, as well as in the development of neural circuits. It has also been shown to be involved in the regulation of the blood-brain barrier, which is the barrier that separates the brain from the surrounding blood vessels and is responsible for controlling the exchange of nutrients and waste products into and out of the brain.

DUX4L5 has been identified as a potential drug target and biomarker for a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. It is also a potential target for cancer, as it has been shown to be involved in the regulation of cell growth and survival.

The role of DUX4L5 in

Protein Name: Double Homeobox 4 Like 5 (pseudogene)

Functions: May be involved in transcriptional regulation

The "DUX4L5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX4L5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DUX4L6 | DUX4L7 | DUX4L8 | DUX4L9 | DUXA | DUXAP10 | DUXAP3 | DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2 | EAPP | Early growth response | EARS2 | EBAG9 | EBF1 | EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P | EBNA1BP2 | EBP | EBPL | ECD | ECE1 | ECE1-AS1 | ECE2 | ECEL1 | ECEL1P1 | ECEL1P2 | ECH1 | ECHDC1 | ECHDC2 | ECHDC3 | ECHS1 | ECI1 | ECI2 | ECI2-DT | ECM1 | ECM2 | ECPAS | ECRG4 | ECSCR